Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Bone marrow as an alternative site for islet transplantation

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Cantarelli, E.
  • Melzi, R.
  • Mercalli, A.
  • Sordi, V.
  • Ferrari, G.
  • Lederer, C. W.
  • Mrak, E.
  • Rubinacci, A.
  • Ponzoni, M.
  • Sitia, G.
  • Guidotti, Luca
  • Bonifacio, E.
  • Piemonti, L.

publication date

  • November 2009

journal

  • Blood  Journal

abstract

  • The liver is the current site for pancreatic islet transplantation, but has many drawbacks due to immunologic and nonimmunologic factors. We asked whether pancreatic islets could be engrafted in the bone marrow (BM), an easily accessible and widely distributed transplant site that may lack the limitations seen in the liver. Syngeneic islets engrafted efficiently in the BM of C57BL/6 mice rendered diabetic by streptozocin treatment. For more than 1 year after transplantation, these animals showed parameters of glucose metabolism that were similar to those of nondiabetic mice. Islets in BM had a higher probability to reach euglycemia than islets in liver (2.4-fold increase, P = .02), showed a compact morphology with a conserved ratio between alpha and beta cells, and affected bone structure only very marginally. Islets in BM did not compromise hematopoietic activity, even when it was strongly induced in response to a BM aplasia-inducing infection with lymphocytic choriomeningitis virus. In conclusion, BM is an attractive and safe alternative site for pancreatic islet transplantation. The results of our study open a research line with potentially significant clinical impact, not only for the treatment of diabetes, but also for other diseases amenable to treatment with cellular transplantation.

subject areas

  • Animals
  • Blood Glucose
  • Bone Marrow
  • Diabetes Mellitus, Experimental
  • Graft Survival
  • Immunohistochemistry
  • Islets of Langerhans
  • Islets of Langerhans Transplantation
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood-2009-03-209973

PubMed ID

  • 19773545
scroll to property group menus

Additional Document Info

start page

  • 4566

end page

  • 4574

volume

  • 114

issue

  • 20

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support